No takes yet. Share an insight, caveat, or question.
Phase I trials reveal dose-proportional pharmacokinetics and moderate accumulation of caspofungin in healthy men, supporting once-daily dosing regimens for fungal infections.
Stone et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: